Pfizer is known for increasing its dividend for 11 years; projected earnings estimate its ratio to rise to 32.92%.
The chart shows strong buying pressure with a healthy and necessary retracement.
The current trading rate is 51.40, which is 10.31 less than this year’s high.
Established in 1849 by cousins Pfizer and Charles Erhart in Brooklyn, New York, Pfizer Inc. is the world’s leading pharmaceutical company. It develops, markets, manufactures, distributes and sells biopharmaceutical products worldwide.
The stock is trading at $51.40, down by 4.12% in the last 24 hours. Its previous close was $53.61, while today’s opening was at a positive note of $53.01. However, the current rate is still down by 10.31, a not-so-easy feat for the company.
Its market cap stands at $288.52 billion, while its volume remains at 65.06 million shares. The projected earnings are at negative 24.77% from $6.46 to $4.86 per share.
Daily Chart Analysis
Source: TradingView
The daily chart analysis
We współpracy z: https://www.thecoinrepublic.com/2022/12/25/pfizer-is-it-a-good-investment-in-the-long-term/
